NCT05852457 Evaluation of the Clinical Utility of Endoscopic Closure Using a Dual Action Tissue (DAT) Clip
| NCT ID | NCT05852457 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AdventHealth |
| Condition | GI Bleeding |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2022-08-31 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2022-08-31 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is designed as a multicenter prospective data recording study to document the performance of the DAT clip as part of standard medical care of patients. No experimental interventions will be performed.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older. * Patients scheduled to undergo endoscopic procedures as part of their routine care in which endoscopic clip closure is clinically indicated: Treatment of bleeding Treatment of perforation and/or fistulas Tissue approximation for mucosal gaps associated with endoscopic resection (e.g., endoscopic mucosal resection, endoscopic submucosal dissection) or third space endoscopy (e.g., peroral endoscopic myotomy in the gastrointestinal tract) Exclusion Criteria: * Any contraindications to performing endoscopy. * Participants in another research protocol that could interfere or influence the outcomes measures of the present study.
Contact & Investigator
Dennis Yang, MD
PRINCIPAL INVESTIGATOR
AdventHealth
Frequently Asked Questions
Who can join the NCT05852457 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying GI Bleeding. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05852457 currently recruiting?
Yes, NCT05852457 is actively recruiting participants. Contact the research team at Dennis.Yang.MD@adventhealth.com for enrollment information.
Where is the NCT05852457 trial being conducted?
This trial is being conducted at Orlando, United States, Fort Wayne, United States.
Who is sponsoring the NCT05852457 clinical trial?
NCT05852457 is sponsored by AdventHealth. The principal investigator is Dennis Yang, MD at AdventHealth. The trial plans to enroll 250 participants.